☆ 4.6 Editorial Material

Integrating new therapies for systemic sclerosis-associated lung fibrosis in clinical practice

LANCET RESPIRATORY MEDICINE (2021)

Get Full Text
Add to Collection

Journal

LANCET RESPIRATORY MEDICINE
Volume 9, Issue 6, Pages 560-562

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/S2213-2600(21)00163-6

Keywords

-

Categories

Critical Care Medicine Respiratory System

Funding

  1. US National Institute of Arthritis and Musculoskeletal and Skin Diseases [K24-AR-063120, R01-AR-0704]
  2. BMS
  3. Bayer
  4. Horizon
  5. Pfizer
  6. CiviBioPharma
  7. CSL Behring
  8. GlaxoSmithKline
  9. Inventiva
  10. Servier

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.